{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:01:27Z","timestamp":1784894487683,"version":"3.55.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The rapid advancement of next-generation omics platforms, bioinformatic data analysis, and novel imaging techniques is transforming biomedical research, especially in pulmonary hypertension. These cutting-edge tools generate vast data, leading to innovative therapeutic and diagnostic possibilities, such as personalized medicine and patient-specific risk stratification. However, while embracing new technologies, it is crucial to integrate decades of hypothesis-driven research with emerging discovery platforms to avoid redundant efforts and enhance scientific progress. At the 2024 American Thoracic Society conference, senior and junior investigators in vascular biology, pulmonary hypertension, and right heart failure engaged in pro and con debates on research paradigms. These discussions explored how evolving disease frameworks fit within the context of traditional research, emphasizing the balance between newer multiomics approaches and classical hypothesis-driven science. Three key objectives were addressed: 1) integrating unbiased analytic methods with traditional frameworks, 2) interpreting new multiomics findings within known pathobiological pathways, and 3) reviewing modern imaging methods for the right ventricle to improve disease understanding. Although omics approaches offer a broad, integrative view and support personalized medicine, they present challenges, such as managing large datasets and ensuring effective clinical translation. Conversely, traditional reductionist approaches, focusing on known genetic alterations and signaling pathways, have led to significant breakthroughs, including the development of current therapies. Combining both approaches holds great potential to drive future discoveries and develop more effective treatments for pulmonary hypertension, a goal that can be achieved only through coordinated, transdisciplinary teams of investigators with diverse skillsets and knowledge working together to advance the field.<\/jats:p>","DOI":"10.1165\/rcmb.2024-0519ps","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T15:53:58Z","timestamp":1743177238000},"page":"200-209","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":1,"title":["Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0518-9079","authenticated-orcid":false,"given":"Grazyna","family":"Kwapiszewska","sequence":"first","affiliation":[{"name":"Otto Loewi Research Center, Medical University of Graz, Graz, Austria"},{"name":"Institute for Lung Health, Cardiopulmonary Institute, Member of the German Lung Center, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-3204","authenticated-orcid":false,"given":"Christopher","family":"Rhodes","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-7104","authenticated-orcid":false,"given":"Marlene","family":"Rabinovitch","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Pediatrics"},{"name":"Vera Moulton Wall Center for Pulmonary Vascular Disease, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-5660","authenticated-orcid":false,"given":"Catherine","family":"Simpson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0601-4975","authenticated-orcid":false,"given":"Paul","family":"Hassoun","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-335X","authenticated-orcid":false,"given":"Kenzo","family":"Ichimura","sequence":"additional","affiliation":[{"name":"Vera Moulton Wall Center for Pulmonary Vascular Disease, and"},{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2892","authenticated-orcid":false,"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Inserm UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, H\u00f4pital Bic\u00eatre (Assistance Publique\u2013H\u00f4pitaux de Paris), Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3868-5186","authenticated-orcid":false,"given":"Edda","family":"Spiekerkoetter","sequence":"additional","affiliation":[{"name":"Vera Moulton Wall Center for Pulmonary Vascular Disease, and"},{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2026072407073254200_bib1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.202105-1118OC","article-title":"Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension","volume":"205","author":"Rhodes","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S2213-2600(18)30409-0","article-title":"Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis","volume":"7","author":"Rhodes","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026072407073254200_bib3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/CIRCRESAHA.121.319969","article-title":"Harnessing big data to advance treatment and understanding of pulmonary hypertension","volume":"130","author":"Rhodes","year":"2022","journal-title":"Circ Res"},{"key":"2026072407073254200_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41467-018-03672-4","article-title":"Identification of rare sequence variation underlying heritable pulmonary arterial hypertension","volume":"9","author":"Gr\u00e4f","year":"2018","journal-title":"Nat Commun"},{"key":"2026072407073254200_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-018-0566-x","article-title":"Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease","volume":"10","author":"Zhu","year":"2018","journal-title":"Genome Med"},{"key":"2026072407073254200_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.122.061940","article-title":"SOX17 enhancer variants disrupt transcription factor binding and enhancer inactivity drives pulmonary hypertension","volume":"147","author":"Walters","year":"2023","journal-title":"Circulation"},{"key":"2026072407073254200_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/CIRCRESAHA.122.320845","article-title":"Sox17 deficiency promotes pulmonary arterial hypertension via HGF\/c-Met signaling","volume":"131","author":"Park","year":"2022","journal-title":"Circ Res"},{"key":"2026072407073254200_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.202203-0450OC","article-title":"SOX17 deficiency mediates pulmonary hypertension: at the crossroads of sex, metabolism, and genetics","volume":"207","author":"Sangam","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib9","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/HYPERTENSIONAHA.123.21241","article-title":"E2F1 mediates SOX17 deficiency-induced pulmonary hypertension","volume":"80","author":"Yi","year":"2023","journal-title":"Hypertension"},{"key":"2026072407073254200_bib10","doi-asserted-by":"crossref","first-page":"2200656","DOI":"10.1183\/13993003.00656-2022","article-title":"An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants","volume":"60","author":"Montani","year":"2022","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib11","doi-asserted-by":"crossref","first-page":"e2206139","DOI":"10.1002\/advs.202206139","article-title":"SOX17 is a critical factor in maintaining endothelial function in pulmonary hypertension by an exosome-mediated autocrine manner","volume":"10","author":"Zou","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026072407073254200_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2026072407073254200_bib13","doi-asserted-by":"crossref","first-page":"eaba6480","DOI":"10.1126\/scitranslmed.aba6480","article-title":"iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension","volume":"13","author":"Gu","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026072407073254200_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201408-1528OC","article-title":"RNA sequencing analysis detection of a novel pathway of endothelial dysfunction in pulmonary arterial hypertension","volume":"192","author":"Rhodes","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1164\/rccm.202003-0510OC","article-title":"Whole-blood RNA profiles associated with pulmonary arterial hypertension and clinical outcome","volume":"202","author":"Rhodes","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib16","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","author":"Spiekerkoetter","year":"2013","journal-title":"J Clin Invest"},{"key":"2026072407073254200_bib17","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/CIRCULATIONAHA.120.048845","article-title":"ALDH1A3 coordinates metabolism with gene regulation in pulmonary arterial hypertension","volume":"143","author":"Li","year":"2021","journal-title":"Circulation"},{"key":"2026072407073254200_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCRESAHA.118.313374","article-title":"Smooth muscle contact drives endothelial regeneration by BMPR2-Notch1-mediated metabolic and epigenetic changes","volume":"124","author":"Miyagawa","year":"2019","journal-title":"Circ Res"},{"key":"2026072407073254200_bib19","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1038\/s41467-023-43039-y","article-title":"Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension","volume":"14","author":"Isobe","year":"2023","journal-title":"Nat Commun"},{"key":"2026072407073254200_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/2045-8932.97606","article-title":"Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming","volume":"2","author":"Fessel","year":"2012","journal-title":"Pulm Circ"},{"key":"2026072407073254200_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCULATIONAHA.116.024602","article-title":"Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension","volume":"135","author":"Rhodes","year":"2017","journal-title":"Circulation"},{"key":"2026072407073254200_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-1-60761-500-2_24","article-title":"Polyamine regulatory pathways as pharmacologic targets in pulmonary arterial hypertension","volume":"661","author":"Gillespie","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"2026072407073254200_bib23","doi-asserted-by":"crossref","first-page":"e12304","DOI":"10.1002\/pul2.12304","article-title":"Differential drug response in pulmonary arterial hypertension: the potential for precision medicine","volume":"13","author":"Miller","year":"2023","journal-title":"Pulm Circ"},{"key":"2026072407073254200_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201507-1456OC","article-title":"Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension","volume":"192","author":"Rhee","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib25","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib26","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2022.05.038","article-title":"Clinical characteristics and transplant-free survival across the spectrum of pulmonary vascular disease","volume":"80","author":"Hemnes","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026072407073254200_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/CIRCRESAHA.118.313911","article-title":"Discovery of distinct immune phenotypes using machine learning in pulmonary arterial hypertension","volume":"124","author":"Sweatt","year":"2019","journal-title":"Circ Res"},{"key":"2026072407073254200_bib29","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.42632","article-title":"Metabolomic differences in connective tissue disease-associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort","volume":"75","author":"Simpson","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026072407073254200_bib30","first-page":"1452","article-title":"Association of biomarker-based treatment strategies with response rates and progression-free survival in refractory malignant neoplasms: a meta-analysis","volume":"2","author":"Schwaederle","year":"2016","journal-title":"J. Am. Med. Assoc. Oncol"},{"key":"2026072407073254200_bib31","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2015.61.5997","article-title":"Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials","volume":"33","author":"Schwaederle","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026072407073254200_bib32","doi-asserted-by":"crossref","first-page":"eaao4583","DOI":"10.1126\/scitranslmed.aao4583","article-title":"Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients","volume":"9","author":"Michelakis","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026072407073254200_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1164\/rccm.202009-3481OC","article-title":"Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension: a multicenter, double-blind, randomized, placebo-controlled trial","volume":"204","author":"Zamanian","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib34","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary arterial hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"N Engl J Med"},{"key":"2026072407073254200_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"Lane","year":"2000","journal-title":"Nat Genet"},{"key":"2026072407073254200_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene","volume":"67","author":"Deng","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2026072407073254200_bib37","doi-asserted-by":"crossref","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"2026072407073254200_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N Engl J Med"},{"key":"2026072407073254200_bib40","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"2026072407073254200_bib41","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib42","doi-asserted-by":"crossref","first-page":"100925","DOI":"10.1016\/j.gim.2023.100925","article-title":"Defining the clinical validity of genes reported to cause pulmonary arterial hypertension","volume":"25","author":"Welch","year":"2023","journal-title":"Genet Med"},{"key":"2026072407073254200_bib43","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1164\/rccm.201510-1955OC","article-title":"A selective transforming growth factor-beta ligand trap attenuates pulmonary hypertension","volume":"194","author":"Yung","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026072407073254200_bib44","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"key":"2026072407073254200_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCRESAHA.123.323546","article-title":"3D imaging reveals complex microvascular remodeling in the right ventricle in pulmonary hypertension","volume":"135","author":"Ichimura","year":"2024","journal-title":"Circ Res"},{"key":"2026072407073254200_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCIMAGING.113.000640","article-title":"Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension","volume":"6","author":"Fine","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026072407073254200_bib47","doi-asserted-by":"crossref","first-page":"e003792","DOI":"10.1161\/CIRCIMAGING.115.003792","article-title":"Unique abnormalities in right ventricular longitudinal strain in systemic sclerosis patients","volume":"9","author":"Mukherjee","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026072407073254200_bib48","doi-asserted-by":"crossref","first-page":"e003176","DOI":"10.1161\/CIRCIMAGING.114.003176","article-title":"Characterization of right ventricular remodeling in pulmonary hypertension associated with patient outcomes by 3-dimensional wall motion tracking echocardiography","volume":"8","author":"Ryo","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026072407073254200_bib49","doi-asserted-by":"crossref","first-page":"775039","DOI":"10.3389\/fcvm.2021.775039","article-title":"Clinical relevance of right atrial functional response to treatment in pulmonary arterial hypertension","volume":"8","author":"Richter","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026072407073254200_bib50","doi-asserted-by":"crossref","first-page":"2045894020961739","DOI":"10.1177\/2045894020961739","article-title":"Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension","volume":"10","author":"Yogeswaran","year":"2020","journal-title":"Pulm Circ"},{"key":"2026072407073254200_bib51","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.chest.2022.12.045","article-title":"Derivation of a risk score (REVEAL-ECHO) based on echocardiographic parameters of patients with pulmonary arterial hypertension","volume":"163","author":"El-Kersh","year":"2023","journal-title":"Chest"},{"key":"2026072407073254200_bib52","doi-asserted-by":"crossref","first-page":"2401323","DOI":"10.1183\/13993003.01323-2024","article-title":"Risk stratification and treatment goals in pulmonary arterial hypertension","volume":"64","author":"Dardi","year":"2024","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib53","doi-asserted-by":"crossref","first-page":"2102419","DOI":"10.1183\/13993003.02419-2021","article-title":"External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry","volume":"59","author":"Boucly","year":"2022","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib54","doi-asserted-by":"crossref","first-page":"2102311","DOI":"10.1183\/13993003.02311-2021","article-title":"COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension","volume":"60","author":"Hoeper","year":"2022","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","article-title":"Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension","volume":"159","author":"Benza","year":"2021","journal-title":"Chest"},{"key":"2026072407073254200_bib56","doi-asserted-by":"crossref","first-page":"2400197","DOI":"10.1183\/13993003.00197-2024","article-title":"Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension","volume":"64","author":"Boucly","year":"2024","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib57","doi-asserted-by":"crossref","first-page":"2401321","DOI":"10.1183\/13993003.01321-2024","article-title":"Pathophysiology of the right ventricle and its pulmonary vascular interaction","volume":"64","author":"Hemnes","year":"2024","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib58","doi-asserted-by":"crossref","first-page":"2401128","DOI":"10.1183\/13993003.01128-2024","article-title":"Emerging multimodality imaging techniques for the pulmonary circulation","volume":"64","author":"Rajagopal","year":"2024","journal-title":"Eur Respir J"},{"key":"2026072407073254200_bib59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(17)30161-3","article-title":"Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study","volume":"5","author":"Rhodes","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026072407073254200_bib60","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/CIRCULATIONAHA.122.061501","article-title":"Serum and pulmonary expression profiles of the activin signaling system in pulmonary arterial hypertension","volume":"147","author":"Guignabert","year":"2023","journal-title":"Circulation"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/73\/2\/200\/66194639\/ajrcmb_73_2_200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/73\/2\/200\/66194639\/ajrcmb_73_2_200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:07:46Z","timestamp":1784891266000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/73\/2\/200\/8404923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,1]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2024-0519ps","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"2024-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}